To Bravo or not? A comparison of wireless esophageal pH monitoring and conventional pH catheter to evaluate non-erosive gastroesophageal reflux disease in a multiracial Asian cohort

Journal of Digestive Diseases

Volumn 11, Issue 1, 2010, Pages 19-27

  Ang, Daphne ^a   Teo, Eng Kiong ^a   Ang, Tiing Leong ^a   Ong, Jeannie ^a   Poh, Choo Hean ^a   Tan, Jessica ^a   Fock, Kwong Ming ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

Acid reflux; Bravo wireless capsule; Esophageal pH; Nasopharyngeal pH catheter; Non erosive reflux disease

Indexed keywords

PROTON PUMP INHIBITOR;

ADULT; ARTICLE; ASIAN; CAPSULE ENDOSCOPY; CATHETER; COMPUTER PROGRAM; CONTROLLED STUDY; ENDOSCOPE; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; ESOPHAGEAL PH MONITORING; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 76349104841     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2009.00409.x     Document Type: Article

References (37)

1. Shaheen NJ, Hansen RA, Morgan DR. The burden of gastrointestinal and liver diseases. Am J Gastroenterol 2006, 101:2128-38.
2. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006, 4:398-407.
3. Winter JW, Heading RC. The nonerosive reflux disease-gastroesophageal reflux disease controversy. Curr Opin Gastroenterol 2008, 24:509-15.
4. Spechler SJ. Epidemiology and natural history of gastroesophageal reflux disease. Digestion 1992, 51(1):24-9. Suppl
5. Smout AJPM. Endoscopy negative acid reflux disease. Aliment Pharmacol Ther 1997, 11(2):81-5. Suppl
6. Lind T, Havelund T, Carlsson R. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997, 32:974-9.
7. Galmiche JP, Clouse RE, Balint A. Functional esophageal disorders. Gastroenterol 2006, 130(5):1459-65.
8. Tack J. Is there a unifying role for visceral hypersensitivity and irritable bowel syndrome in non-erosive reflux disease? Digestion 2008, 78(1):42-5. Suppl
9. Quigley EM. Non-erosive reflux disease, functional heartburn and gastroesophageal reflux disease; insights into pathophysiology and clinical presentation. Chin J Dig Dis 2006, 7:186-90.
10. Shi G, Bruley des Varannes S, Scarpignato C, Le Rhun M, Galmiche JP. Reflux related symptoms in patients with normal esophageal exposure to acid. Gut 1995, 37:457-64.
11. Trimble K, Pryde A, Heading R. Lowered esophageal sensory thresholds in patients with symptomatic but not excess gastroesophageal reflux: evidence for a spectrum of visceral sensitivity in GORD. Gut 1995, 37:7-12.
12. Johnson LF, DeMeester TR. Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux. Am J Gastroenterol 1974, 62:325-32.
13. Kahrilas P, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996, 110:1982-96.
14. Pandolfino JE, Richter JE, Ours T. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003, 98:740-9.
15. Wong WM, Bautista J, Dekel R. Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h esophageal pH monitoring - a randomized trial. Aliment Pharmacol Ther 2005, 21:155-63.
16. Wenner J, Johnsson F, Johansson J, Oberg S. Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial. Am J Gastroenterol 2007, 102:239-45.
17. Grigolon A, Bravi I, Cantu P, Conte D, Penagini R. Wireless pH monitoring: better tolerability and lower impact on daily activities. Dig Liver Dis 2007, 39:720-4.
18. Schneider JH, Kramer KM, Konigsrainer A, Granderath FA. Ambulatory pH monitoring with a wireless system. Surg Endosc 2007, 21:2076-80.
19. Fass R, Hell R, Sampliner RE. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci 1999, 44:2263-9.
20. Gillies RS, Stratford JM, Booth MI, Dehn TC. Esophageal pH monitoring using the Bravo catheter-free radio capsule. Eur J Gastroenterol Hepatol 2007, 19:57-63.
21. Prakash C, Clouse RE. Value of extended recording time with wireless pH monitoring in evaluating gastro-esophageal reflux disease. Clin Gastroenterol Hepatol 2005, 3:329-34.
22. Ward EM, Devault KR, Bouras EP. Successful esophageal pH monitoring with a catheter-free system. Aliment Pharmacol Ther 2004, 19:449-54.
23. Tu CH, Lee YC, Wang HP, Wu MS, Chiu HM, Lin JT. Ambulatory esophageal pH monitoring by using a wireless system: a pilot study in Taiwan. Hepatogastroenterology 2004, 51:1586-9.
24. Lee YC, Wang HP, Chiu HM. Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring. Gastrointest Endosc 2005, 62:834-41.
25. Bruley des Varannes S, Mion F, Ducrotte P. Simultaneous recordings of esophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut 2005, 54:1682-86.
26. Kahrilas PJ. Review article: gastro-oesophageal reflux disease as a functional gastrointestinal disorder. Aliment Pharmacol Ther 2004, 20(7):50-5. Suppl
27. Dent J, Brun J, Fendrick AM. An evidence based appraisal of reflux disease management: the Genval Workshop report. Gut 1999, 44(2):S1-16. Suppl
28. Weusten BL, Roelofs JM, Akkermans LK, Van Berge-Henegouwen GP, Smout AJ. The symptom association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterol 1994, 107:1741-5.
29. Wiener GJ, Richter JE, Copper JB, Wu WC, Castell DO. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol 1988, 83:358-61.
30. Kahrilas PJ, Lin S, Chen J, Manka M. The effect of hiatus hernia on gastro-esophageal junction pressure. Gut 1999, 44:476-82.
31. Ayazi S, Lipham J, Portale G. Bravo catheter free pH monitoring: normal values, concordance, optimal diagnostic thresholds and accuracy. Clin Gastroenterol Hepatol 2009, 7:60-7.
32. Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol 1996, 91(8):1532-8.
33. Pandolfino JE, Schreiner MA, Lee T, Zhang Q, Boniquit C, Kahrilas P. Comparison of the Bravo™ wireless and Digitrapper™ catheter-based pH systems for measuring esophageal acid exposure. Am J Gastroenterol 2005, 100:1466-76.
34. Pandolfino JE, Zhang Q, Schreiner MA, Ghosh S, Roth MP, Kahrilas PJ. Acid reflux event detection using the Bravo wireless versus the slimline catheter pH systems: why are the numbers so different? Gut 2005, 54:1687-92.
35. Wenner J, Johnsson F, Johansson J, Oberg S. Wireless esophageal pH monitoring: feasibility, safety and normal values in healthy subjects. Scan J Gastroenterol 2005, 40:768-74.
36. Tseng D, Rizvi AZ, Fennerty MB. Forty-eight hour pH monitoring increases sensitivity in detecting abnormal esophageal acid exposure. J Gastrointest Surg 2005, 9:1043-51.
37. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-esophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid and gas reflux. Gut 2004, 53:1024-31.